Adverse Event Clinical Research
1.0.1 - STU1

Adverse Event Clinical Research, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-ig/ and changes regularly. See the Directory of published versions

## MedicationRequest: Medication Request for bresentrik

Page standards status: Informative

Generated Narrative: MedicationRequest

Resource MedicationRequest "medicationrequest-for-bresentrik"

identifier: `http://www.bmc.nl/portal/medstatements`/1234568900-studyDrug (use: official)

status: active

intent: order

### Medications

- | Reference
* | Medication/bresentrik: bresentrik 2mg tablet

subject: Patient/JanetPatient: Janet " CLINICAL TRIAL PATIENT"

supportingInformation: ResearchStudy/BreastCancerTrial: http://baseUrlOfHospitalHolding/PlanDefinition/protocol-for-the-ResearchStudy

authoredOn: 2023-04-05

requester: : Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD

### Reasons

- | Concept
* | Breast Cancer (SNOMED CT#254837009)

> dosageInstruction

> sequence: 1

> text: 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL

> timing: Once per 1 days

> route: Oral route (qualifier value) (SNOMED CT#26643006)

> > doseAndRate

> dispenseRequest

> numberOfRepeatsAllowed: 1

> quantity: 600 mg (Details: UCUM code mg = 'mg')

> ### ExpectedSupplyDurations

> - | Value | Unit | System | Code
> * | 30 | days | Unified Code for Units of Measure (UCUM) | d